Roberts M Scot

CIK 00017059051 companyGAITHERSBURG, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001705905

Recent Transactions

50 trades

Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-07-31$3.14/sh+846→ 74,066 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-02$6.64/sh−2,316→ 73,220 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-02-02+7,775→ 7,775 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-02+7,775→ 75,536 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-01+6,166→ 69,562 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-01$6.64/sh−1,801→ 67,761 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-02-01+6,166→ 0 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-31$5.18/sh+3,184→ 63,396 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-30$7.00/sh−2,709→ 60,212 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-30+9,275→ 18,550 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-30+9,275→ 62,921 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2025-01-27+183,600→ 183,600 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-27+63,400→ 63,400 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-25+14,600→ 43,800 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-25+14,600→ 57,910 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-25$6.98/sh−4,264→ 53,646 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-07-31$5.41/sh+650→ 43,310 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-02+7,775→ 44,990 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-02-02−7,775→ 15,550 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-02$9.32/sh−2,330→ 42,660 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-01+6,166→ 39,016 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-01$9.88/sh−1,801→ 37,215 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-02-01−6,166→ 6,166 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-31$2.69/sh+5,860→ 32,850 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-01-30−9,275→ 27,825 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-30+9,275→ 29,699 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-30$9.80/sh−2,709→ 26,990 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2024-01-25+58,400→ 58,400 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2024-01-25+163,200→ 163,200 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-07-31$2.81/sh+568→ 20,424 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2023-02-02−7,775→ 23,325 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-02+7,775→ 22,231 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-02$15.04/sh−2,375→ 19,856 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-01$13.78/sh−2,183→ 14,456 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-01+6,166→ 16,639 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2023-02-01−6,166→ 12,332 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-01-31$10.21/sh+1,436→ 10,473 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2023-01-30+37,100→ 37,100 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2023-01-30+105,000→ 105,000 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-07-31$6.86/sh+732→ 9,037 total
Sale
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-07-05$12.00/sh−10,182→ 8,305 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-07-05$2.95/sh+787→ 18,487 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock Options (option to buy)
2022-07-05−787→ 14,250 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-07-01$2.60/sh+4,019→ 21,719 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock Options (option to buy)
2022-07-01−4,019→ 8,750 total
Sale
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-07-01$12.00/sh−26,982→ 17,700 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-07-01$2.95/sh+22,963→ 44,682 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock Options (option to buy)
2022-07-01−22,963→ 15,037 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock Options (option to buy)
2022-06-29−5,462→ 12,769 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-06-29$2.60/sh+5,462→ 23,162 total

Companies

Altimmune, Inc.
Chief Scientific Officer
$ALT

Recent Filings

Address

C/O ALTIMMUNE, INC., 910 CLOPPER ROAD, SUITE 201S

GAITHERSBURG, MD, 20878

View on SEC.gov